Description

Huo et al identified factors that can help identify a patient with ductal carcinoma in situ (DCIS) diagnosed on needle core biopsy who is likely to have invasive carcinoma. This can help select patients for sentinel lymph node biopsy. The authors are from M.D. Anderson Cancer Center in Houston.


 

Parameters:

(1) lesion seen on imaging studies as calcification (Ca+2) vs mass

(2) cancerization of the lobules

(3) size of the lesion in cm

(4) nuclear grade (Grade 1 = low; Grade 2 or 3 = high)

Ca+2/Mass

Cancerization

size in cm

nuclear grade

Probability

Ca+2

no

<= 1.5 cm

low

0.0195

Ca+2

no

<= 1.5 cm

high

0.086

Ca+2

no

> 1.5 cm

low

0.057

Ca+2

no

> 1.5 cm

high

0.224

Ca+2

yes

<= 1.5 cm

low

0.047

Ca+2

yes

<= 1.5 cm

high

0.189

Ca+2

yes

> 1.5 cm

low

0.130

Ca+2

yes

> 1.5 cm

high

0.415

mass

no

<= 1.5 cm

low

0.046

mass

no

<= 1.5 cm

high

0.185

mass

no

> 1.5 cm

low

0.128

mass

no

> 1.5 cm

high

0.410

mass

yes

<= 1.5 cm

low

0.106

mass

yes

<= 1.5 cm

high

0.360

mass

yes

> 1.5 cm

low

0.265

mass

yes

> 1.5 cm

high

0.632

 

where:

• The odds ratio for mass lesion and lobular cancerization was about 2.4. The odds ratio for a lesion > 1.5 cm was 3.1, while nuclear grade was 4.8 (with a p value 0.14).

 

Interpretation:

• Probabilities <= 0.19 was considered low.

• A probability >= 0.22 was considered high.

• A patient with a high probability of lymph node metastases was a candidate for sentinel lymph node biopsy.

 


To read more or access our algorithms and calculators, please log in or register.